Ad is loading...
CTCX
Price
$0.23
Change
-$0.05 (-17.86%)
Updated
Nov 15 closing price
PSTX
Price
$2.76
Change
-$0.45 (-14.02%)
Updated
Nov 15 closing price
108 days until earnings call
Ad is loading...

CTCX vs PSTX

Header iconCTCX vs PSTX Comparison
Open Charts CTCX vs PSTXBanner chart's image
Carmell
Price$0.23
Change-$0.05 (-17.86%)
Volume$749.52K
CapitalizationN/A
Poseida Therapeutics
Price$2.76
Change-$0.45 (-14.02%)
Volume$702.04K
CapitalizationN/A
CTCX vs PSTX Comparison Chart
Loading...
CTCX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CTCX vs. PSTX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTCX is a StrongSell and PSTX is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CTCX: $0.23 vs. PSTX: $2.76)
Brand notoriety: CTCX and PSTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTCX: 12% vs. PSTX: 128%
Market capitalization -- CTCX: $4.85M vs. PSTX: $269M
CTCX [@Biotechnology] is valued at $4.85M. PSTX’s [@Biotechnology] market capitalization is $269M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTCX’s FA Score shows that 0 FA rating(s) are green whilePSTX’s FA Score has 0 green FA rating(s).

  • CTCX’s FA Score: 0 green, 5 red.
  • PSTX’s FA Score: 0 green, 5 red.
According to our system of comparison, PSTX is a better buy in the long-term than CTCX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTCX’s TA Score shows that 2 TA indicator(s) are bullish while PSTX’s TA Score has 4 bullish TA indicator(s).

  • CTCX’s TA Score: 2 bullish, 6 bearish.
  • PSTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PSTX is a better buy in the short-term than CTCX.

Price Growth

CTCX (@Biotechnology) experienced а -21.89% price change this week, while PSTX (@Biotechnology) price change was -10.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

CTCX is expected to report earnings on Mar 17, 2023.

PSTX is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PSTX($269M) has a higher market cap than CTCX($4.85M). PSTX YTD gains are higher at: -17.857 vs. CTCX (-93.911). CTCX has higher annual earnings (EBITDA): -15.42M vs. PSTX (-98.04M). PSTX has more cash in the bank: 238M vs. CTCX (2.2M). CTCX has less debt than PSTX: CTCX (799K) vs PSTX (83.7M). PSTX has higher revenues than CTCX: PSTX (88.5M) vs CTCX (12.3K).
CTCXPSTXCTCX / PSTX
Capitalization4.85M269M2%
EBITDA-15.42M-98.04M16%
Gain YTD-93.911-17.857526%
P/E RatioN/AN/A-
Revenue12.3K88.5M0%
Total Cash2.2M238M1%
Total Debt799K83.7M1%
TECHNICAL ANALYSIS
Technical Analysis
CTCXPSTX
RSI
ODDS (%)
Bearish Trend 4 days ago
38%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
35%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
33%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
45%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
67%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
59%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
CTCX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGHIX10.800.01
+0.09%
Sextant Global High Income
NMMEX15.02-0.04
-0.27%
Northern Active M Emerging Market Equity
JEMKX9.47-0.06
-0.63%
JHancock Emerging Markets Equity R2
ASYMX14.72-0.22
-1.47%
Alger Weatherbie Specialized Growth Y
ASLWX129.36-2.90
-2.19%
American Century Select Y

CTCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTCX has been loosely correlated with ATNF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CTCX jumps, then ATNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTCX
1D Price
Change %
CTCX100%
-17.73%
ATNF - CTCX
41%
Loosely correlated
-6.72%
PRQR - CTCX
31%
Poorly correlated
-3.29%
EYEN - CTCX
27%
Poorly correlated
-70.04%
URGN - CTCX
25%
Poorly correlated
-5.65%
PSTX - CTCX
23%
Poorly correlated
-14.02%
More

PSTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSTX has been loosely correlated with NTLA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTX
1D Price
Change %
PSTX100%
-14.02%
NTLA - PSTX
50%
Loosely correlated
-7.61%
ALEC - PSTX
50%
Loosely correlated
-17.21%
QNRX - PSTX
48%
Loosely correlated
+2.17%
EDIT - PSTX
45%
Loosely correlated
-3.97%
INZY - PSTX
43%
Loosely correlated
-8.89%
More